sibutramine has been researched along with neuropeptide y in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 6 (85.71) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fanelli, E; Grignaschi, G; Samanin, R; Scagnol, I | 1 |
| Dunn-Meynell, AA; Levin, BE | 1 |
| Bing, C; Brown, M; Heal, D; King, P; Pickavance, L; Wilding, J | 1 |
| Birtles, S; Block, MH; Boyer, S; Carroll, D; Clarkson, P; Ellershaw, L; Foote, KM; Loxham, SJ; Masters, DJ; McAulay, P; Pease, JE; Teague, JL; Turnbull, AV | 1 |
| Gura, T | 1 |
| Abecia, LC; Casado, A; Casis, L; Echevarría, E; Macarulla, MT; Portillo, MP; Rodríguez, VM | 1 |
| Baranowska, B; Baranowska-Bik, A; Boguradzka, A; Chmielowska, M; Martyńska, L; Mazurczak-Pluta, T; Wolińska-Witort, E | 1 |
1 trial(s) available for sibutramine and neuropeptide y
| Article | Year |
|---|---|
Sibutramine therapy in obese women--effects on plasma neuropeptide Y (NPY), insulin, leptin and beta-endorphin concentrations.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Analysis of Variance; Appetite Depressants; Appetite Regulation; beta-Endorphin; Cyclobutanes; Female; Humans; Insulin; Leptin; Neuropeptide Y; Obesity; Reference Values; Selective Serotonin Reuptake Inhibitors; Statistics, Nonparametric | 2005 |
6 other study(ies) available for sibutramine and neuropeptide y
| Article | Year |
|---|---|
Studies on the role of serotonin receptor subtypes in the effect of sibutramine in various feeding paradigms in rats.
Topics: Animals; Appetite Depressants; Cyclobutanes; Dose-Response Relationship, Drug; Eating; Male; Neuropeptide Y; Oxadiazoles; Piperazines; Rats; Rats, Sprague-Dawley; Receptors, Serotonin | 1999 |
Sibutramine alters the central mechanisms regulating the defended body weight in diet-induced obese rats.
Topics: Adipose Tissue; Animals; Appetite Depressants; Arcuate Nucleus of Hypothalamus; Body Weight; Cyclobutanes; Energy Intake; Epinephrine; Feeding Behavior; Gene Expression Regulation; Homeostasis; Leptin; Neuropeptide Y; Norepinephrine; Obesity; Organ Size; Pro-Opiomelanocortin; Rats; RNA, Messenger | 2000 |
Sibutramine reduces feeding, body fat and improves insulin resistance in dietary-obese male Wistar rats independently of hypothalamic neuropeptide Y.
Topics: Adipose Tissue; Animals; Appetite Depressants; Body Weight; Cyclobutanes; Diet; Feeding Behavior; Hypothalamus; Insulin Resistance; Leptin; Male; Neurons; Neuropeptide Y; Obesity; Rats; Rats, Wistar; RNA, Messenger | 2001 |
Selective antagonism of the NPY Y5 receptor does not have a major effect on feeding in rats.
Topics: Animals; Appetite Depressants; Cerebral Ventricles; Cyclobutanes; Energy Intake; Feeding Behavior; Injections, Intraventricular; Kinetics; Neuropeptide Y; Peptide Fragments; Rats; Rats, Wistar; Rats, Zucker; Receptors, Neuropeptide Y | 2002 |
Obesity drug pipeline not so fat.
Topics: Agouti-Related Protein; alpha-MSH; Animals; Anti-Obesity Agents; Appetite; Arcuate Nucleus of Hypothalamus; Ciliary Neurotrophic Factor; Clinical Trials as Topic; Cyclobutanes; Energy Intake; Ghrelin; Humans; Hunger; Intercellular Signaling Peptides and Proteins; Lactones; Leptin; Mice; Nerve Tissue Proteins; Neurons; Neuropeptide Y; Obesity; Orlistat; Peptide Fragments; Peptide Hormones; Peptide YY; Phentermine; Proteins; Receptors, Corticotropin; Receptors, Melanocortin; Weight Loss | 2003 |
Sibutramine decreases body weight gain and increases energy expenditure in obese Zucker rats without changes in NPY and orexins.
Topics: Adipose Tissue; Animals; Appetite Depressants; Body Composition; Carrier Proteins; Cyclobutanes; Drinking; Eating; Energy Metabolism; Hypothalamus; Intracellular Signaling Peptides and Proteins; Male; Neuropeptide Y; Neuropeptides; Obesity; Orexins; Organ Size; Oxygen Consumption; Rats; Rats, Zucker; Weight Gain | 2003 |